Infinity Pharmaceuticals Inc. buy Amped
Start price
29.07.21
/
0%
€2.38
Target price
28.07.22
-
Performance (%)
-72.64%
End price
29.07.22
€0.65
Summary
This prediction ended on 29.07.22 with a price of €0.65. Massive losses of -72.64% were the result for the BUY prediction by Amped. This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Infinity Pharmaceuticals Inc. | - | - | - |
iShares Core DAX® | -1.822% | -1.170% | 11.771% |
iShares Nasdaq 100 | -0.241% | 1.961% | 40.760% |
iShares Nikkei 225® | -2.310% | -1.758% | 21.493% |
iShares S&P 500 | -0.835% | 1.309% | 28.068% |
According to Amped what are the pros and cons of Infinity Pharmaceuticals Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
High valuation
Revenue decline/stagnation expected
Sustainability is little important
Higher risks for its business
Little known brand
high free float
Comments by Amped for this prediction
In the thread Infinity Pharmaceuticals Inc. diskutieren
Buy Infinity Pharmaceuticals Inc.
In the thread Trading Infinity Pharmaceuticals Inc.
Die von Amped gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Amped for Infinity Pharmaceuticals Inc.
Infinity Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.76
28.07.21
28.07.21
-
28.07.22
28.07.22
35.23%
29.07.21
29.07.21
Probably not worthwhile Investment
High valuation
Revenue decline/stagnation expected
Sustainability is little important